Picture of SpringWorks Therapeutics logo

SWTX — SpringWorks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

SpringWorks Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of 54 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.25.  The mean expectation of seven analysts
for the quarter was for a loss of $1.11 per share. Wall Street
expected results to range from $-1.32 to -99 cents per share.
    * Revenue was $59.73 million​; analysts expected $34.34
million. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of 54 cents​.
    * The company reported a quarterly loss of $39.92 million.
    * SpringWorks Therapeutics Inc shares had fallen by 11.8%
this
quarter and lost 9.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $63.13 
This summary was machine generated from LSEG data August 7 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.11          -0.54          Beat
 Mar. 31 2024      -1.17          -1.18          Missed
 Dec. 31 2023      -1.24          -1.45          Missed
 Sep. 30 2023      -1.33          -1.27          Beat

Recent news on SpringWorks Therapeutics

See all news